Stem Cell Transplantation
HSCT feasible in infants with acute lymphoblastic leukemia
Published in Cancer Weekly, February 28th, 2006
"Infants with acute lymphoblastic leukemia (ALL) have a poor prognosis when treated with standard chemotherapy. A subset of these infants, particularly those with mixed-lineage leukemia (MLL) rearrangements, has a high likelihood of relapse.
"Hematopoietic stem cell transplantation (HSCT) performed early in first remission may improve outcome," scientists in the United States report.
According to D.A. Jacobsohn and colleagues at Children's Memorial Hospital in Chicago, "We present the results of 16 patients with infant ALL who were...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2006-02-28)
More Articles from Cancer Weekly
- Bladder Cancer
Polymorphism in hGPX1 gene may be used as marker for bladder cancer recurrence - Colon Cancer
Disease-free survival after 3-year follow-up proposed as end point for colon cancer clinical trial - Glioma
Dihydroartemisinin enhanced radiosensitivity of human glioma cells - Leukemia
NS-187 proposed as novel agent for imatinib-resistant leukemia - Lung Cancer
Altered EGFR signaling implicated in genetic susceptibility to lung cancer - Acute Myeloid Leukemia
Impaired C/EBP alpha function contributes directly to AML development - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
